MIR.N Hits 20-Day Low Amid AI Infrastructure Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 20 Nov 25
Source: Fool
Shares of MIR.N declined sharply today, hitting a 20-day low as investor sentiment weakened. The stock's recent performance reflects increased bearish momentum, likely influenced by broader market trends in the AI infrastructure sector. Despite the anticipated surge in data center capacity, with projections indicating capital expenditures could exceed $1 trillion by 2028, MIR's position appears vulnerable. Analysts suggest that while companies like Comfort Systems USA and Vertiv Holdings are capitalizing on this growth, MIR may need to enhance its operational strategies to remain competitive in the evolving landscape.
Analyst Views on MIR
Wall Street analysts forecast MIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MIR is 30.67 USD with a low forecast of 29.00 USD and a high forecast of 34.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 25.290
Low
29.00
Averages
30.67
High
34.00
Current: 25.290
Low
29.00
Averages
30.67
High
34.00
About MIR
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
